Ventricular arrhythmia can be detected in ambulatory ECG monitoring in individuals with or without cardiac disease, and its prognostic value varies, depending on the underlying condition. The use of continuous or intermittent ambulatory ECG monitoring can be helpful for diagnosis when there is a high pre-test probability of identifying a transient arrhythmia. In addition, Holter monitoring can be used for risk stratification of patients, in the context of the prognostic value of non-sustained ventricular arrhythmias in various clinical settings, as discussed in detail.
Keywords: ACS; ARVD; Ambulatory ECG monitoring; BrS; Brugada syndrome; CAD; CHD; CIEDs; CMR; CPVT; CVD; DCM; ECG; ELR; EP; HF; HOCM; Holter monitoring; ICD; ILR; LQTS; LV; LVEF; MCOT; MI; NSTE-ACS; NSVT; NYHA; New York Heart Association; Nonsustained ventricular tachycardia; PVC; RV; RVOT; Risk stratification; SCD; SQTS; ST-elevation myocardial infarction; STEMI; T-wave alternans; TWA; VF; VT; Ventricular arrhythmia; acute coronary syndrome; arrhythmogenic right ventricular dysplasia; cardiac magnetic resonance; cardiovascular disease; cardiovascular implantable electronic devices; catecholaminergic polymorphic VT; congenital heart disease; coronary artery disease; dilated cardiomyopathy; electrocardiographic; electrophysiology; external loop reorder; heart failure; hypertrophic cardiomyopathy; implantable cardioverter defibrillator; implantable loop recorder; left ventricular; left ventricular ejection fraction; long QT syndrome; mobile or real-time cardiac telemetry; myocardial infarction; non-ST-elevation acute coronary syndrome; nonsustained ventricular tachycardia; premature ventricular complex; right ventricular; right ventricular outflow tract; short QT syndrome; sudden cardiac death; ventricular fibrillation; ventricular tachycardia.
© 2013.